Table 1 |
|||||||||
|
Proportion of pediatric patients with lupus nephritis-associated ESRD who received renal biopsies and medications prior to ESRD |
|||||||||
|
Renal biopsy |
Corticosteroids |
HCQ |
Immunosuppressants |
||||||
|
|
|||||||||
|
n (%) |
P valuea |
n (%) |
P valuea |
n (%) |
P valuea |
n (%) |
P valuea |
||
|
|
|||||||||
|
Total |
254 |
||||||||
|
Sex |
|||||||||
|
Female |
182 |
89 (49) |
0.15 |
167 (92) |
0.47 |
117 (64) |
0.38 |
121 (66) |
0.85 |
|
Male |
72 |
28 (39) |
64 (89) |
42 (58) |
47 (65) |
||||
|
Race/ethnicity |
|||||||||
|
White |
25 |
14 (56) |
0.52 |
22 (88) |
0.19 |
11 (44) |
1 × 106 |
13 (52) |
0.02 |
|
Black |
155 |
74 (48) |
139 (90) |
91 (59) |
103 (66) |
||||
|
Hispanic |
48 |
21 (44) |
47 (98) |
44 (92) |
34 (71) |
||||
|
Asian |
17 |
- |
16 (94) |
- |
15 (88) |
||||
|
Native |
- |
- |
- |
- |
- |
||||
|
SES group |
|||||||||
|
Quartile 1 - lowest |
63 |
37 (59) |
0.02b |
60 (95) |
0.21b |
36 (57) |
0.33b |
42 (67) |
0.95b |
|
Quartile 2 |
63 |
27 (43) |
56 (89) |
41 (65) |
42 (67) |
||||
|
Quartile 3 |
63 |
29 (46) |
58 (92) |
39 (62) |
42 (67) |
||||
|
Quartile 4 - highest |
64 |
23 (36) |
56 (88) |
43 (67) |
42 (66) |
||||
|
Region of residence |
|||||||||
|
Northeast |
35 |
10 (29) |
0.09 |
30 (86) |
0.004 |
22 (63) |
0.01 |
30 (58) |
0.53 |
|
Midwest |
52 |
26 (50) |
43 (83) |
23 (44) |
23 (66) |
||||
|
South |
123 |
63 (51) |
120 (98) |
81 (66) |
85 (69) |
||||
|
West |
44 |
18 (41) |
38 (86) |
33 (75) |
30 (68) |
||||
|
Residence in health professional shortage area |
|||||||||
|
Not HPSA |
13 |
- |
0.78 |
13 (100) |
0.48 |
- |
0.09 |
11 (85) |
0.12 |
|
HPSA |
240 |
110 (46) |
217 (90) |
151 (63) |
157 (65) |
||||
|
Pediatric rheumatologist per state |
|||||||||
|
Quartile 1 - lowest |
63 |
38 (60) |
0.0002b |
59 (94) |
0.24b |
35 (56) |
0.02b |
43 (68) |
0.50b |
|
Quartile 2 |
64 |
34 (53) |
62 (97) |
37 (58) |
46 (72) |
||||
|
Quartile 3 |
72 |
30 (42) |
63 (88) |
46 (64) |
42 (58) |
||||
|
Quartile 4 - highest |
55 |
15 (27) |
47 (85) |
41 (75) |
37 (67) |
||||
|
|
|||||||||
|
-, cell sizes under 11 have been suppressed in accordance with Centers for Medicare and Medicaid Services policy to protect privacy. aP value for chi-square tests and Fisher's exact tests for small cell counts. bP value for Cochran-Armitage Trend tests. |
|||||||||
|
Hiraki et al. Arthritis Research & Therapy 2012 14(Suppl 3):A58 doi:10.1186/ar3992 |
|||||||||